The Economist

The plan to rescue Denmark’s weight-loss pioneer

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
The Economist

The plan to rescue Novo Nordisk

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...

A Stumble for a Former Star: Novo Nordisk's Challenging Year

The coming year, 2026, is shaping up as a critical operational and financial test. A head-to-head comparative study between Novo Nordisk's CagriSema and Eli Lilly's Zepbound, scheduled for 2026, will ...

8 FDA-approved weight loss drugs: What are they & what are their side effects?

FDA-approved weight loss medications include injections (Wegovy®, Zepbound®, etc.) and pills, like Qsymia® and Xenical®. Most ...

Hims and Hers to offer weight-loss treatments in UK

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

Hims and Hers to start weight-loss jab subscription in UK

Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...